The use of metabolic measurements in angiographic regression trials
Publisher
Springer Netherlands
Reference58 articles.
1. Watts GF. Lipid-lowering therapy and regression of atherosclerosis. Endocrinol Metab. 1994;1:71–87.
2. Brensike JF, Levy RI, Kelsey SF, et al. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation. 1984;69:313–24.
3. Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233–40.
4. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolaemia. Report of the Program on the Surgical Control of the Hyperlipidaemias (POSCH). N Engl J Med. 1990;323:946–55.
5. Ornish D, Brown SE, Scherwitz L, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990;336:129–33.